Biopharmaceutical company that is creating the next generation of antibody drug conjugates using its Fleximer-ADC technology
- Year invested 2012
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website mersana.com/
- Company Status IPO/Public (NASDAQ: MRSN)